Skip to main content
Loading

Addressing challenges faced for optimal bispecific and immunocytokines engineering

14 Apr 2025
Formats & Scaffolds
  • Choosing and changing partners: What is the desired biological mechanism of action?
  • Bispecific or Combination, that is the question.
  • Format in service of function: design based on function, stability, immunogenicity, TPP
  • Scaffold Architecture: constant and variable region placements to optimize efficacy
Industry Expert
Maria P. MacWilliams, Vice President of Molecular Biology - Tavotek Biotherapeutics